Welcome to our dedicated page for Jack Henry & Associates SEC filings (Ticker: JKHY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Jack Henry & Associates, Inc. filings document regulatory disclosures for a Nasdaq-listed financial technology company with common stock traded under JKHY. Its material-event reports record operating results, deconversion revenue, non-GAAP presentation topics, stock repurchase activity, cash and debt disclosures, and the company's role providing technology services to banks and credit unions.
The filing record also covers capital-structure and governance matters, including a revolving unsecured credit agreement, annual meeting voting results, director elections, advisory compensation votes, and an equity incentive plan for employees and non-employee directors. These disclosures frame the company's financing arrangements, shareholder approvals, executive-compensation governance, and recurring financial reporting.
Jack Henry & Associates (JKHY) director reported a compensation-related equity event. On 11/11/2025, 1,159 restricted stock units (RSUs) vested from a grant dated November 15, 2024, which was scheduled to vest on the earlier of the day before the 2025 annual meeting or the first anniversary of the grant. The reporting person elected to defer settlement of the 1,159 RSUs under the Non-Employee Director Deferred Compensation Plan, to be paid in cash or common stock, at the issuer’s option, upon termination as a director or on specified future dates. Each RSU equals one share of JKHY common stock.
Jack Henry & Associates (JKHY) reported an insider equity change by a director. On 11/11/2025, the reporting person converted 1,159 restricted stock units into common stock at $0 per share under transaction code M.
Following this transaction, the reporting person directly holds 93,749 shares. The RSUs were granted on 11/15/2024 and were set to vest in full on the earlier of the day before the company’s 2025 annual meeting of stockholders or the first anniversary of the grant date. After the conversion, 0 derivative securities remain held.
Jack Henry & Associates (JKHY) disclosed an insider transaction by its COO on a Form 4. On 11/10/2025, the executive sold 227 shares of common stock at a price of $160.83 per share, coded “S” for sale.
Following the transaction, the COO beneficially owned 1,420 shares, held directly. The filing was signed by Andrew Potter under power of attorney for Shanon G. McLachlan.
Jack Henry & Associates (JKHY) director Thomas A. Wimsett reported a Form 4 transaction. On 11/11/2025, 1,159 shares of common stock were acquired at $0 via the vesting/settlement of previously granted restricted stock units (transaction code M). After the transaction, he directly owned 39,875 shares.
The RSUs were granted on 11/15/2024 and vested in full on the earlier of the day before the 2025 annual meeting or the first anniversary of the grant.
Jack Henry & Associates (JKHY) reported an insider equity change. Director Matthew C. Flanigan converted 1,159 restricted stock units into common stock on 11/11/2025 (Transaction Code M) at $0 per share. Following the transaction, he directly owned 44,894 shares.
Each RSU equals one share of JKHY common stock. The RSUs were granted on November 15, 2024 and vest in full on the earlier of the day before the 2025 annual meeting or the first anniversary of the grant date.
Jack Henry & Associates (JKHY) disclosed a routine insider equity settlement. On 11/11/2025, director Tammy S. LoCascio converted restricted stock units into 1,159 shares of common stock under Transaction Code M at a stated price of $0. After this settlement, her directly owned holdings were 1,524 shares.
The filing notes the RSUs were granted on 11/15/2024 and vested in full on the earlier of the day before the Issuer’s 2025 Annual Meeting of Stockholders or the first anniversary of the grant date. Following the conversion, 0 derivative securities remained.
Jack Henry & Associates (JKHY) reported solid Q1 FY2026 results. Revenue rose to $644.7 million from $601.0 million as Payments and Complementary drove growth, while Core was steady. Operating income increased to $184.1 million, and net income reached $144.0 million, translating to diluted EPS of $1.97.
Services and support delivered $376.9 million and processing $267.9 million. By segment, Payments grew 9.0% to $230.9 million, Complementary rose 10.2% to $194.2 million, and Core edged up 0.5% to $195.3 million, with margin improvement across segments. Operating cash flow was $120.6 million. The company invested $98.5 million, including the $42.4 million acquisition of Victor Technologies to expand Payments-as-a-Service, and spent $62.0 million on share repurchases alongside dividends of $0.58 per share. Deferred revenue ended at $321.1 million (current and non-current). As of October 24, 2025, shares outstanding were 72,377,132.
Jack Henry & Associates, Inc. filed a current report to note that it released its fiscal 2026 first quarter results. On November 4, 2025, the company issued a press release announcing these quarterly results, which is included in the filing as Exhibit 99.1.
Jack Henry & Associates (JKHY) filed an 8-K stating it issued a press release announcing its deconversion revenue for the fiscal first quarter ended September 30, 2025. The press release is attached as Exhibit 99.1.
Jack Henry & Associates, Inc. is soliciting votes for its November 12, 2025 Annual Meeting with a record date of September 16, 2025. The Board nominated ten directors (the Board was expanded from nine to ten on August 22, 2025 and appointed Gregory R. Adelson, CEO, as a director). The Board reports 8 of 10 nominees are independent, directors face term and age limits, and the company maintains proxy access allowing holders of 3% for 3 years to nominate up to two directors or 20% of the Board.
The Human Capital & Compensation Committee disclosed fiscal 2025 incentive outcomes: a three‑year TSR of 3.48% led to a 52.7% payout on TSR performance shares; a 0.9% operating margin expansion produced a 180% payout for that metric. The fiscal 2025 adjusted operating income target was $540.7M; pre-bonus adjusted operating income was $571.5M (100.1% of target), yielding a 100.2% payout of target annual bonuses. The Board asks stockholders to approve a new 2025 Equity Incentive Plan reserving 4,700,000 shares (expected overhang ~6.93%).